Ultragenyx Pharmaceutical Inc.
RARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001515673
In the last 90 days, Ultragenyx Pharmaceutical Inc. insiders filed 0 open-market purchases and 5 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $3.55B in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Ultragenyx Pharmaceutical Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 237
- +20 vs. Q3 2023
- Shares held
- 80.4M
- +10.3M (+14.7%) vs. Q3 2023
- Total value
- $3.84B
- +$1.34B (+53.8%) vs. Q3 2023
- New holders
- 43
- 94 more added
- Sold out
- 23
- 75 more reduced
4 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RARE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 311 | $3.55B |
| Q1 2026 | 298 | $2.05B |
| Q4 2025 | 288 | $2.16B |
| Q3 2025 | 303 | $2.87B |
| Q2 2025 | 311 | $3.42B |
| Q1 2025 | 301 | $3.25B |
| Q4 2024 | 314 | $3.68B |
| Q3 2024 | 302 | $4.83B |
| Q2 2024 | 275 | $3.63B |
| Q1 2024 | 270 | $3.73B |
| Q4 2023 | 237 | $3.84B |
| Q3 2023 | 221 | $2.52B |
| Q2 2023 | 243 | $3.21B |
| Q1 2023 | 230 | $2.76B |
| Q4 2022 | 228 | $3.15B |
| Q3 2022 | 233 | $2.81B |
| Q2 2022 | 225 | $4.03B |
| Q1 2022 | 240 | $4.87B |
| Q4 2021 | 235 | $5.69B |
| Q3 2021 | 223 | $6.01B |
| Q2 2021 | 242 | $6.24B |
| Q1 2021 | 255 | $7.73B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Ultragenyx Pharmaceutical Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Emerald Mutual Fund Advisers Trust | 385,340 | $18.4M | 0.98% | −1,983−0.5% | Reduced |
| Woodline Partners LP | 400,124 | $19.1M | 0.21% | +194,641+94.7% | Added |
| Invesco Ltd. | 430,018 | $20.6M | 0.00% | +44,577+11.6% | Added |
| Nuveen Asset Management, LLC | 457,447 | $21.9M | 0.01% | +26,775+6.2% | Added |
| Charles Schwab Investment Management Inc | 471,825 | $22.6M | 0.01% | +75,100+18.9% | Added |
| Emerald Advisers, LLC | 482,138 | $23.1M | 0.99% | −9,551−1.9% | Reduced |
| Hudson Bay Capital Management LP | 490,000 | $23.4M | 0.21% | −244,272−33.3% | Reduced |
| Morgan Stanley | 597,549 | $28.6M | 0.00% | +102,060+20.6% | Added |
| Fred Alger Management, LLC | 603,976 | $28.9M | 0.16% | −34,890−5.5% | Reduced |
| Great Point Partners LLC | 648,000 | $31.0M | 5.28% | −79,426−10.9% | Reduced |
| Jacobs Levy Equity Management, Inc | 718,978 | $34.4M | 0.17% | −29,300−3.9% | Reduced |
| First Light Asset Management, LLC | 744,665 | $35.6M | 2.86% | −380,367−33.8% | Reduced |
| Norges Bank | 770,506 | $36.8M | 0.01% | +172,418+28.8% | Added |
| Avidity Partners Management LP | 844,500 | $40.4M | 1.54% | +300,500+55.2% | Added |
| Camber Capital Management LP | 900,000 | $43.0M | 1.50% | +900,000 | New |
| FMR LLC | 992,951 | $47.5M | 0.00% | −34,834−3.4% | Reduced |
| Bank of New York Mellon Corp | 1,010,830 | $48.3M | 0.01% | +389,124+62.6% | Added |
| Pictet Asset Management Holding SA | 1,023,136 | $48.9M | 0.05% | +153,748+17.7% | Added |
| Adage Capital Partners GP, L.L.C. | 1,025,000 | $49.0M | 0.10% | +935,000+1,038.9% | Added |
| First Trust Advisors LP | 1,163,077 | $55.6M | 0.06% | −38,611−3.2% | Reduced |
| Deutsche Bank AG | 1,172,866 | $56.1M | 0.03% | +225,134+23.8% | Added |
| Geode Capital Management, LLC | 1,283,622 | $61.4M | 0.01% | +200,335+18.5% | Added |
| Baker Bros. Advisors LP | 1,466,547 | $70.1M | 0.80% | +100,000+7.3% | Added |
| Marshall Wace, LLP | 1,489,486 | $71.2M | 0.14% | +548,723+58.3% | Added |
| Alliancebernstein L.P. | 1,578,603 | $75.5M | 0.03% | +46,098+3.0% | Added |
| Rock Springs Capital Management LP | 1,754,038 | $83.9M | 2.07% | +277,597+18.8% | Added |
| Suvretta Capital Management, LLC | 2,126,306 | $101.7M | 4.65% | +1,446,847+212.9% | Added |
| Alkeon Capital Management LLC | 2,241,832 | $107.2M | 0.70% | +298,017+15.3% | Added |
| Clearbridge Investments, LLC | 2,383,492 | $114.0M | 0.10% | +89,922+3.9% | Added |
| Federated Hermes, Inc. | 2,446,500 | $117.0M | 0.29% | +250,000+11.4% | Added |
| State Street Corp | 3,252,502 | $155.5M | 0.01% | +684,644+26.7% | Added |
| Price T Rowe Associates Inc | 3,448,698 | $164.9M | 0.02% | +288,538+9.1% | Added |
| Sands Capital Management, LLC | 4,118,008 | $196.9M | 0.60% | +1,540,791+59.8% | Added |
| Wellington Management Group LLP | 4,415,029 | $211.1M | 0.04% | −780,851−15.0% | Reduced |
| BlackRock Inc. | 5,238,400 | $250.5M | 0.01% | +159,191+3.1% | Added |
| RTW Investments, LP | 6,887,086 | $329.3M | 5.14% | +1,481,997+27.4% | Added |
| Vanguard Group Inc | 8,673,432 | $414.8M | 0.01% | +1,440,264+19.9% | Added |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −174,945−100.0% | Sold out |
| Bank of Nova Scotia | 0 | $0 | 0.00% | −42,451−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −37,591−100.0% | Sold out |
| Natixis | 0 | $0 | 0.00% | −33,100−100.0% | Sold out |
| AlphaCentric Advisors LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −29,178−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −23,436−100.0% | Sold out |
| Y-Intercept (Hong Kong) Ltd | 0 | $0 | 0.00% | −15,442−100.0% | Sold out |
| HighVista Strategies LLC | 0 | $0 | 0.00% | −14,591−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −12,800−100.0% | Sold out |
| DnB Asset Management AS | 0 | $0 | 0.00% | −12,674−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −8,856−100.0% | Sold out |
| Point72 Middle East FZE | 0 | $0 | 0.00% | −7,243−100.0% | Sold out |
| Aigen Investment Management, LP | 0 | $0 | 0.00% | −6,732−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −6,409−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −6,152−100.0% | Sold out |
| Headlands Technologies LLC | 0 | $0 | 0.00% | −3,351−100.0% | Sold out |
| Essex Investment Management Co LLC | 0 | $0 | 0.00% | −1,481−100.0% | Sold out |
| Cutler Group LP | 0 | $0 | 0.00% | −1,010−100.0% | Sold out |
| Clear Street Markets LLC | 0 | $0 | 0.00% | −657−100.0% | Sold out |
| Loomis Sayles & Co L P | 0 | $0 | 0.00% | −152−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −73−100.0% | Sold out |
| Crewe Advisors LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| International Biotechnology Trust PLC | – | – | – | – | Not filed |
| CHI Advisors LLC | – | – | – | – | Not filed |
| Virginia Retirement Systems Et Al | – | – | – | – | Not filed |
| Column Capital Advisors, LLC | – | – | – | – | Not filed |